Actinium Pharma's Stock Surge Amid Buyout Speculations Following Fusion Acquisition by AstraZeneca
Tuesday, 19 March 2024, 16:31
Actinium Pharma's Stock Surge
Actinium Pharma (ATNM) witnessed a notable increase in its stock value after AstraZeneca (AZN) announced the acquisition of Fusion Pharma (FUSN).
Buyout Prospects Highlighted
H.C. Wainwright emphasized the buyout potential for Actinium Pharma, which has garnered attention in the market.
The acquisition of Fusion Pharma by AstraZeneca has sparked speculations in the industry, leading to increased interest in Actinium Pharma as a potential acquisition target.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.